Fritextsökning
Innehållstyper
-
KI’s freezer fiasco investigated: A chain of failures
A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...
-
Förlikning i babypuderskandal stoppas av domstol
Det amerikanska läkemedelsbolaget Johnson & Johnson har för en andra gång fått avslag av en domare om en konkursansökan för dotterbolaget LTL Management, mest k...
-
Investigations against AstraZeneca: ”Chinese interests may be behind them”
Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.
-
5 tips för smidigare inventering
Inventering kanske inte är det roligaste man kan göra, speciellt inte om man gör det en gång per år och manuellt. Då är risken stor att det tar tid och blir krå...
-
För Wibe Group var ett affärssystem i molnet en självklarhet
I det anrika företaget Wibes historia har uppfinningsrikedom och förmåga att anpassa sig till omvärlden alltid varit närvarande och är idag del av företagets DN...
-
Efficient use of blood plasma
Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...
-
Han får vetenskapspris för upptäckten av den inflammatoriska reflexen
Den amerikanske neurokirurgen och uppfinnaren Kevin J. Tracey tilldelas Hans Wigzells Forskningsstiftelses vetenskapliga pris på 100 000 dollar. Han får det bla...
-
Precision and accuracy in liquid handling
How to evaluate and optimize liquid handling performance
-
Marie Gårdmark: ”The situation is not satisfactory”
”The legislative tool-box is limited, but carrots in the form of longer exclusivity has already proven successful, this has for example increased registration o...
-
Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell
Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Mich...
-
The new Astra Zeneca CEO: “An incredibly exciting phase”
Almost 27 years have passed since Per Alfredsson from Södertälje stepped into Astra Zeneca as a newly hired engineer. After countless different roles, including...
-
Björn Ursing: Physicians new role in AI driven healthcare
”AI could be the key we need for tomorrow’s healthcare, but it is not a stand-alone tool”, writes Björn Ursing in a column about how the role for physicians cha...
-
Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap
From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...
-
Heidi Stensmyren is eager for new challenges in the biotech industry
management roles,” she says.
-
High-tech companies are increasingly focusing on health
Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more...
-
Webinar: Clinical evaluation and clinical investigation of medical devices
Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.
-
Mathias Uhlén’s protein atlas is recognised as a global resource
The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...
-
CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”
become disease-free, at least of those treated with Yescarta, which are the ones I know best,” says Gunilla Enblad, Chairman of the national working group for CAR-T treatment.
-
Webinar: What is Regulatory Affairs?
This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.
-
Anna Törner: ”Orphan designation läkemedelsutvecklingens ’petite robe noire’”
Det är så lätt att klamra sig fast vid olika regulatoriska incitament, som orphan designation, utan att egentligen veta vad de innebär och på vilket sätt de kan...
-
We will now publish more news in English – and offer yet another newsletter
Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.
-
Nordisk VD för ZEISS lämnar över stafettpinnen
Walther Heger, Managing Director för ZEISS Nordics sedan 28 år, har beslutat sig för att avsluta en imponerande karriär. I slutet av september kommer Walther He...
-
On the hunt for high throughput diagnostics
Global diagnostics companies and laboratories are in a race against time to adapt testing capacity to current demand. Due to the global COVID 19 pandemic, the d...
-
Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”
It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...